Unfortunately, there is also a report about no significant difference in infiltration by CD56+ cells between patients with different outcomes, so it is possible that NK cells are engaged in the tumour elimination mainly in the early phase of tumour development due to development of specific immunosuppressive mechanisms during tumour progression [63]. The gene discussed is NCAM1; the disease is neoplasm.